Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis 2026-09-22
  2. Smartphone Passive Digital Phenotyping in Frontotemporal Lobar Degeneration 2026-09-21
  3. Diagnostic Value of Large Language Model-Extracted Gross Brain Findings in Neurodegenerative Diseases 2026-09-14

Studies

1,027 studies carry this tag.

Date range

1967 to 2026

Top journals

  • Neurology 107
  • Brain : a journal of neurology 71
  • Movement disorders : official journal of the Movement Disorder Society 53
  • Annals of neurology 34
  • The Lancet. Neurology 34

315 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Impact of hypersexuality on spousal carers of patients with Parkinson’s disease and frontotemporal dementia: a qualitative study

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BMJ Open 2025-04-01 Lewy body dementia

    The thematic analysis identified 12 themes: manifestations, sexual practices, impact, control, emotional formulations, beliefs in causes of hypersexuality and attributions, relationship with the partner, dealing with hypersexuality, coping with hypersexuality, self-image, stigma and professional help-seeking.

  2. Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer s & Dementia 2025-04-01 Lewy body dementia

    Females with sporadic bvFTD showed worse compulsive behavior (p = 0.026) and language impairments (p = 0.024) compared to females with genetic bvFTD (n = 152).

  3. Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 63 out of 100. Alzheimer s & Dementia 2025-04-01 Lewy body dementia

    While sex differences were not apparent at asymptomatic stages, females showed more rapid declines across all outcomes in symptomatic stages compared to males.

  4. Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Alzheimer s & Dementia 2025-04-01 Lewy body dementia

    Symptomatic females with genetic FTD had lower frontal cortical thickness than males, and the C9orf72 subgroup showed lower-than-expected frontal cortical thickness for a given level of executive functioning.

  5. Validation of the neuropathological criteria of the fourth Consortium on dementia with Lewy Bodies in autopsy cases from psychiatric hospitals

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Psychiatry and Clinical Neurosciences 2025-03-31 Clinical safety

    Sixteen of 30 cases with DLB pathology had no parkinsonism, which represented diverse nigral neurodegeneration.

  6. Alice in Wonderland Syndrome in dementia with Lewy bodies: a case report exploring visual cognition dysfunction

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Frontiers in Neurology 2025-03-27 Lewy body dementia

    This is the first reported case of AIWS in a patient with DLB.

  7. Systematic review of differentially abundant proteins in people with Lewy body dementia

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Acta neuropsychiatrica 2025-03-27 Inflammation and the immune system

    Our meta-analyses confirmed significantly lower CSF TAU levels in DLB and CSF SYUA levels in PDD, when compared to Alzheimer's disease.

  8. Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degeneration

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of Neurology 2025-03-25 Lewy body dementia

    Radial diffusivity analyses detected impaired bilateral cerebello-frontal, cerebello-parietal, and cerebello-temporal connectivity in all study groups along the ALS-FTD spectrum.

  9. Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. The journal of nutrition health & aging 2025-03-23 Lewy body dementia

    A total of 798 patients (154 with probable DLB and 644 with AD) were included, and the mean age was 81.4 years (SD 6.33).

  10. Digital gait biomarkers in Parkinson’s disease: susceptibility/risk, progression, response to exercise, and prognosis

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. npj Parkinson s Disease 2025-03-21 Prevention and risk

    This narrative review examines the utility of gait digital biomarkers in Parkinson's disease (PD) research and clinical trials across four contexts: disease susceptibility/risk, disease progression, response to exercise, and fall prediction.

  11. Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Neurology 2025-03-20 Lewy body dementia

    = 0.029). Despite the absence of overt nOH, patients with DLB show covert dysautonomia encompassing adrenergic, parasympathetic, and sudomotor dysfunction, highlighting the importance of standardized autonomic evaluation.

  12. Dopaminergic changes in the subgenual cingulate cortex in dementia with lewy bodies associates with presence of depression

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Translational Psychiatry 2025-03-20 Lewy body dementia

    In addition to the core clinical features of fluctuating cognition, visual hallucinations, and parkinsonism, individuals with dementia with Lewy bodies (DLB) frequently experience chronic and debilitating major depression.

  13. Neuroimaging of psychosis, agitation, and affective disturbance in Alzheimer’s disease, dementia with Lewy bodies, and mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. International Psychogeriatrics 2025-03-18 Lewy body dementia

    Three factors (psychosis, agitation, and affective disturbance) were extracted for AD.

  14. Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of Alzheimer s Disease 2025-03-14 Lewy body dementia

    Early NPS burden as well as NPS severity progression rate, independently of cognitive status, might be useful clinical metrics and may help predict underlying pathological diagnoses.

  15. Domestic violence in Lewy body dementia: A national study

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Journal of Alzheimer s Disease 2025-03-14 Clinical safety

    A descriptive study using a transversal national online survey to evaluate the prevalence and characteristics of behavioral and psychological symptoms (BPSD) of dementia with Lewy bodies (DLB), and specifically, the perpetration of violent acts against primary caregivers. 196 responses, obtained in one month, were analyzed.

  16. Genome-wide association study of neuropathological features in Lewy body disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Brain 2025-03-14 Lewy body dementia

    APOE ε4) was associated with a greater severity of each of Braak NFT stage [odds ratio (OR) = 3.07, P = 2.34 × 10-32], Thal amyloid phase (OR = 3.57, P = 3.28 × 10-29) and LBD subtype (OR = 1.78, P = 9.85 × 10-9), with similar findings observed in the independent replication series (Braak NFT stage, OR = 2.30, P = 2.70 × 10-11; Thal amyloid phase, OR = 3.17, P = 6.39 × 10-18; LBD subtype, OR = 2.68, P = 3.85 × 10-10).

  17. Key motor and non-motor features in early dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Frontiers in Neurology 2025-03-13 Lewy body dementia

    Early-stage DLB closely resembles PD in motor symptoms but has more neuropsychiatric non-motor symptoms compared to PD and overall non-motor symptoms than AD.

  18. Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Psychiatry and Clinical Neurosciences 2025-03-13 Lewy body dementia

    NPS were highly prevalent (≥90%) in early and late bvFTD.

  19. Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Nature Neuroscience 2025-03-13 Lewy body dementia

    Recent studies suggest the existence of brain-first and body-first subtypes within the Lewy body disorder (LBD) spectrum, including Parkinson's disease.

  20. Use of artificial intelligence in neurological disorders diagnosis: A scientometric study

    ✓ Peer-reviewed alzhub usefulness score 34 out of 100. World Journal of Methodology 2025-03-06 Digital health tools

    Research on AI's role in diagnosing neurological disorders is becoming widely recognized for its growing importance.

  21. Hospice Use Among Medicare Beneficiaries With Parkinson Disease and Dementia With Lewy Bodies

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. JAMA Network Open 2025-03-04 Lewy body dementia

    Of 11 327 324 Medicare beneficiaries enrolled in hospice between 2010 and 2020 who met eligibility criteria (mean [SD] age, 85.2 [7.5] years; 781 763 [63.0%] female), there were 958 182 (8.4%) with a primary diagnosis of AD, 232 864 (2.1%) with PD, and 49 340 (0.4%) with DLB.

  22. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of Neurology 2025-03-01 Mild cognitive impairment

    Subjects with PD-SCD do not consistently show cognitive decline, but rather exhibit a heterogeneous progression.

  23. Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data‐driven clinicopathologic study

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer s & Dementia 2025-03-01 Lewy body dementia

    Among 635 AD patients without LB, 62 (9.7%) presented parkinsonism, which correlated with reduced nigral neuron density (p < 0.01).

  24. Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 32 out of 100. Journal of Alzheimer s Disease 2025-03-01 Getting a diagnosis

    BackgroundDespite dementia with Lewy bodies (DLB) being the second most common form of neurodegenerative dementia, more than 80% of DLB cases are initially misdiagnosed.

  25. Structural insights and milestones in TDP-43 research: A comprehensive review of its pathological and therapeutic advances

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. International Journal of Biological Macromolecules 2025-03-01 Brain tissue and pathology

    Transactive response (TAR) DNA-binding protein 43 (TDP-43) is a critical RNA/DNA-binding protein involved in various cellular processes, including RNA splicing, transcription regulation, and RNA stability.

  26. Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Acta Neuropathologica Communications 2025-02-24 Lewy body dementia

    The enzyme pair PINK1 and PRKN together orchestrates a cytoprotective mitophagy pathway that selectively tags damaged mitochondria with phospho-serine 65 ubiquitin (pS65-Ub) and directs them for autophagic-lysosomal degradation (mitophagy).

  27. Altered spatiotemporal brain dynamics of interoception in behavioural-variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. EBioMedicine 2025-02-22 Lewy body dementia

    In bvFTD patients, longer interoceptive-ACWs than controls were observed in the bilateral fronto-temporal and parietal regions.

  28. Clinical implication of anemia in older patients with dementia with lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Aging Clinical and Experimental Research 2025-02-18 Disparities

    Participants in the study had an average age of 85.4 ± 7.1 years.

  29. Overlap in the diagnostic criteria of frontotemporal dementia syndromes with parkinsonism

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Journal of Alzheimer s Disease 2025-02-16 Lewy body dementia

    BackgroundDifferentiating neurodegenerative diseases can be difficult in the clinical setting.

  30. Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Cortex 2025-02-11 Getting a diagnosis

    Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder, with considerable variability of age-at-onset.

  31. From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Molecular Neurodegeneration 2025-02-11 Risk factors

    Parkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy are synucleinopathies, characterized by neuronal loss, gliosis and the abnormal deposition of α-synuclein in vulnerable areas of the nervous system.

  32. Behavioural changes in frontotemporal dementia and their cognitive and neuroanatomical correlates

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Brain 2025-02-10 Getting a diagnosis

    We found a wide range of behavioural changes across FTD.

  33. Frontotemporal dementia. How to deal with its diagnostic complexity?

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Expert Review of Neurotherapeutics 2025-02-06 Lewy body dementia

    Frontotemporal dementia (FTD) encompasses a group of heterogeneous neurodegenerative disorders.

  34. Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Science Translational Medicine 2025-02-05 Lewy body dementia

    We used an untargeted mass spectrometric approach, tandem mass tag proteomics, for the identification of proteomic signatures in genetic frontotemporal dementia (FTD).

  35. Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia 2025-02-01 Lewy body dementia

    cBF volume declined at comparable rates in iRBD-to-PD and iRBD-to-DLB converters, but atrophy was more severe at DLB phenoconversion. cBF atrophy correlated with attention, executive, and memory deficits.

  36. The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Brain 2025-01-31 Lewy body dementia

    Based on positive/negative results on the different biomarkers, subjects were classified as 'AD-LB-' (n = 304), 'AD+LB-' (n = 335), 'AD+LB+' (n = 158) and 'AD-LB+' (n = 68).

  37. Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

    ✓ Peer-reviewed alzhub usefulness score 63 out of 100. Nature Communications 2025-01-29 Lewy body dementia

    DOPA Decarboxylase (DDC) has been proposed as a cerebrospinal fluid (CSF) biomarker with increased concentrations in Lewy body disorders (LBDs) and highest levels in patients receiving dopaminergic treatment.

  38. Investigating neuropathological correlates of hyperactive and psychotic symptoms in dementia: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Frontiers in dementia 2025-01-29 Disease mechanisms

    This systematic review aims to elucidate the neuropathological basis of the HIDA and psychosis domains, exploring whether distinct proteinopathies and neural circuit dysfunctions are associated with these symptoms.

  39. Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of Parkinson s Disease 2025-01-27 Risk factors

    BackgroundSleep disturbances often precede motor symptoms in neurodegenerative diseases like Parkinson's disease (PD) and dementia with Lewy bodies (DLB).

  40. Association of Alzheimer’s and Lewy body disease pathology with basal forebrain volume and cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer s Research & Therapy 2025-01-27 Lewy body dementia

    In a heterogeneous autopsy sample, AD and LB pathology both contribute to cholinergic basal forebrain degeneration whereas hippocampus atrophy is more specifically related to AD pathology.

  41. Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer s & Dementia 2025-01-27 Lewy body dementia

    The DLB group had reduced stride velocity, step length, and stride width variability, as well as increased double support percentage (%DS) and variability in step length, swing time, and step time compared to the AD and CU groups.

  42. Azygos Vein Stenosis in Frontotemporal Dementia Sagging Brain Syndrome

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. American Journal of Neuroradiology 2025-01-23 Lewy body dementia

    The mean age of the 3 women and 18 men was 50 years (range, 26-68 years).

  43. Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Movement Disorders Clinical Practice 2025-01-16 Lewy body dementia

    Of 11 subjects with average AUCs above 500,000 units, 7 (64%) developed a central LBD compared to 1 of 20 (5%), with AUCs below the cutoff value (P = 0.0011 by log-rank test).

  44. The association of seizure control with neuropathology in dementia

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Brain 2025-01-14 Long-term cohort studies

    Seizures in people with dementia (PWD) are associated with faster cognitive decline and worse clinical outcomes.

  45. Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. JAMA Neurology 2025-01-13 Lewy body dementia

    Thirty-five patients with probable DLB, 37 patients with MCI-LB, and 100 individuals without cognitive impairment were included.

  46. Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Journal of Alzheimer s Disease Reports 2025-01-13 Lewy body dementia

    Gait disturbances (odds ratio (OR) = 19.32; p = 0.01), visual-spatial complaints (OR = 6.06; p = 0.03), and visual hallucinations (OR = 31.06; p = 0.002) predicted DLB compared to AD, along with better memory (OR = 3.42; p = 0.003), naming (OR = 3.35; p = 0.002), and worse processing speed (OR = 0.51; p = 0.01).

  47. The experience of “at‐risk” status for familial frontotemporal dementia (fFTD) and its impact on reproductive decision‐making: A qualitative study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Genetic Counseling 2025-01-12 Lewy body dementia

    Familial frontotemporal dementia (fFTD) is an autosomal dominant heritable form of FTD, onsetting in mid-life, characterized by behavioral and personality changes.

  48. Associations Between Diabetes Mellitus and Neurodegenerative Diseases

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. International Journal of Molecular Sciences 2025-01-10 Risk factors

    Diabetes mellitus (DM) and neurodegenerative diseases/disturbances are worldwide health problems.

  49. Neuropathological contributions to grey matter atrophy and white matter hyperintensities in amnestic dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer s Research & Therapy 2025-01-09 Brain tissue and pathology

    86.8% of patients in this cohort presented more than one pathology.

  50. Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. JAMA Psychiatry 2025-01-08 Genetics

    Expression profiles of amacrine cells (interneurons within the retina) were robustly enriched in schizophrenia genetic risk across mammalian species and in different developmental stages.

From across this tag

10 of the 1,026 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts